In this study, the tissue expression level of CXCL9 was found to correlate with the inflammation and hematologic abnormalities observed in pSS, which is consistent with previous reports, indicating that CXCL9 is more significantly expressed in pSS patients with extraglandular manifestations [27]. The gene discussed is CXCL9; the disease is peeling skin syndrome.